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McCoy cells, murine-derived cells commonly used for propagation of chlamydiae, were found to be efficient
producers of nitric oxide (NO) when primed with murine gamma interferon (IFN-y) and then exposed to the
second signals provided by Escherichia coli lipopolysaccharide, human interleukin-la, murine tumor necrosis
factor a, or Chlamydia trachomatis type H. Murine recombinant IFN-y over a range of 0 to 50 U/mi inhibited
infectivity of C. trachomatis type H in a dose-dependent fashion in McCoy cells while simultaneously inducing
NO production. Quantitation of infectious chiamydia progeny remaining in McCoy cells 48 or 72 h
postinfection revealed that IFN-y-primed McCoy cells reduced chlamydial inclusion-forming units (expressed
as units per milliliter) by 4 log1o units at higher IFN-y concentrations (50 U/ml) compared with control values.
The magnitude of this antichlamydial effect was directly related to increased synthesis of NO, the production
of which was IFN-y dose dependent. The antichlamydial effects of IFN-y were blocked in a dose-dependent
manner by the addition of N-guanidino-monomethyl L-arginine (MLA), an inhibitor of nitric oxide synthesis.
These results suggest that although IFN-y priming of McCoy cells is required for antichlamydial activity, nitric
oxide is a necessary effector molecule involved in the mechanism(s) of IFN--y-induced inhibition of chlamydial
proliferation in this murine cell line. The ability to block the potent antichlamydial effects of IFN-y by
inhibition of a specific enzyme, nitric oxide synthase, may give insights into mechanisms by which IFN-y and
perhaps other cytokines are able to control proliferation of chlamydiae and other intracellular pathogens.
Previous investigators have shown that gamma interferon
(IFN--y) from both human and murine sources exerts a
profound inhibitory effect on chlamydial growth and viability
(4-6, 13, 14, 28, 39, 42-44). While IFN--y induces at least one
antichlamydial effector pathway in human cell lines through
altered tryptophan metabolism (5, 36, 40), other mechanisms
are responsible for IFN-y effects in murine cell lines (12, 36).
One possible mechanism through which IFN--y-dependent
antichlamydial activity is mediated is induction of nitric
oxide. Nitric oxide has potent cytotoxic effects on the
facultative intracellular parasite Cryptococcus neoformans
(20), shistosomula of Schistosoma mansoni (30), intracellu-
lar amastigotes of Leishmania major (21, 22, 34), and intra-
cellular trophozoites of Toxoplasma gondii (la). IFN-y can
prime or direct subsequent cellular enzymatic pathways to
produce nitric oxide when macrophages or nonmacrophage
somatic cells are exposed to a second signal such as lipo-
polysaccharide (LPS), tumor necrosis factor (TNF), or in-
terleukin-1 (IL-1) (2, 33). Nitric oxide is synthesized by the
enzyme nitric oxide synthase, which uses L-arginine as the
sole substrate to eventually produce the end metabolic
products of nitrate, nitrite, and citrulline (2, 24-27, 29).
Mammalian cells have both low-level constitutive nitric
oxide synthase activity and the potential for cytokine-induc-
ible high-output nitric oxide synthase activity (2). Nitric
oxide synthesis in murine cell culture is competitively inhib-
ited by the L-arginine analog N-guanidino-monomethyl
L-arginine (MLA), with no effect on cell proliferation (24,
27). The availability of a specific inhibitor (MLA) for the
cytokine-inducible enzyme which produces nitric oxide al-
lowed testing of the hypothesis that IFN--y mediates its
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antichlamydial effect in murine cells by inducing synthesis of
nitric oxide.
MATERIALS AND METHODS
Growth of chlamydiae and maintenance of cell lines.
Chlamydia trachomatis type H and McCoy cells were ob-
tained from American Type Culture Collection (Rockville,
Md.). McCoy cells were grown in Eagle's minimal essential
medium (EMEM; Flow Laboratories, McLean, Va.) supple-
mented with 10% heat-inactivated fetal bovine serum (ob-
tained from Hyclone, Salt Lake City, Utah) and streptomy-
cin (50 ,ug/ml) at 35°C in a 5% CO2 humidified atmosphere.
Cells were regularly tested and found to be free of contam-
ination with mycoplasmas. Chlamydia stock used for these
experiments was grown on McCoy cell monolayers in the
presence of cycloheximide (2 ,ug/ml) and streptomycin (50
,ug/ml) in 75-cm2 tissue culture flasks (Nunc, Roskilde,
Denmark). Flasks were inoculated with sufficient numbers of
elementary bodies (EBs) to produce inclusions in 80 to 90%
of McCoy cells in monolayers. Centrifugation at 1,000 x g
for 30 min at 35°C was performed to facilitate infection. The
infected monolayers were incubated at 35°C in a 5% CO2
atmosphere for 60 to 72 h prior to purification. The majority
of cells were intact and contained large inclusions visible by
inverted microscopy.
Purification of EBs and RBs. The following method was
adapted from the method of Caldwell et al. (7). Flasks were
freeze-thawed and then sonicated in a water bath sonifier
(Bransonic 12; Branson, Shelton, Conn.) for 10 min. Heparin
was added to a final concentration of 20 U/ml, and sonication
was repeated. Cell debris was pelleted by centrifugation at
1,000 x g for 7 min and discarded. Chlamydiae (EBs and
reticulate bodies [RBs]) from the supernatant were pelleted
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by centrifugation at 16,000 x g for 20 min. The resultant
pellet was gently suspended in SPG (250 mM sucrose, 10
mM sodium phosphate, 5 mM glutamic acid; pH 7.2) and
digested with DNase I (0.1 mg/ml) and RNase A (0.1 mg/ml)
in the presence of 10 mM MgCl2 for 30 min at room
temperature. Chlamydiae were purified by centrifugation at
70,000 x g through 30% (vol/vol) Hypaque (Winthrop Phar-
maceuticals, New York, N.Y.) (7) in an SPG cushion result-
ing in a pellet of EBs and RBs. The pellet was gently
resuspended in SPG and centrifuged through a step gradient
of 30% (vol/vol)-35% (vol/vol)-40% (vol/vol) Hypaque. The
SPG-30% Hypaque layer was discarded (residual cellular
debris), RBs were collected at the 30-35% Hypaque inter-
face, and EBs were collected at the 35-40% Hypaque
interface. EBs and RBs were washed in SPG and resus-
pended in sterile modified standard reaction medium (23)
containing 100 mM TrisCl2, 50 mM KCI, and 5 mM MgCl2
plus 10% dimethyl sulfoxide and frozen at -70°C in 50-,ul
aliquots until used. Inclusion-forming unit (IFU) determina-
tions for EB aliquots were done as described below.
Cytokine priming of McCoy cells to determine their poten-
tial to produce nitric oxide. Recombinant murine IFN-y (2.3
X 107 U/ml) and murine tumor-necrosis factor alpha
(TNF-a) (2.8 x 107 U/ml) were obtained from Genentech
Inc., South San Francisco, Calif. Human IL-la was pro-
vided by Hoffmann-La Roche Inc., Nutley, N.J. Escherichia
coli LPS was obtained from Associates of Cape Cod, Woods
Hole, Mass. MLA was obtained from Chem Biochem Inc.,
Salt Lake City, Utah, and was prepared freshly for each
experiment. Experiments were performed in 24-well tissue
culture plates (Nunc) with confluent McCoy cells (5 x 105
per well) in EMEM supplemented with 1% fetal bovine
serum. Experiments were first done with cytokines and LPS
individually and in combination to determine whether Mc-
Coy cells could produce nitric oxide after IFN-,y priming.
McCoy cell monolayers (5 x 105 per well) in triplicate
received individual treatment with either medium as a con-
trol, IFN--y (20 U/ml), or TNF-ao (50 U/ml). Nitrite was
measured 72 h post-cytokine treatment (see "Determination
of nitrite and nitrate levels" below). Additional McCoy cell
monolayers (5 x 105 per well) in triplicate received the
following combination treatments: (i) IFN--y (20 U/ml) plus
LPS (20 ng/ml), (ii) IFN--y (20 U/ml) plus IL-laL (10 U/ml),
(iii) IFN--y (20 U/ml) plus TNF-ct (25 U/ml), and (iv) IFN-y
(20 U/ml) plus IL-lat (10 U/ml) and TNF-a (25 U/ml). Nitrite
present in the supernatant 72 h after treatment was measured
as described below.
Cytokine priming prior to chlamydial infection. All exper-
iments involving chlamydial infection following cytokine
priming were done in duplicate and included two infected
and two uninfected wells per cytokine treatment. IFN--y (0 to
50 U/ml) was added to cells 24 h prior to infection with EBs
of C. trachomatis type H unless otherwise specified. MLA
was added to the culture medium at the time of chlamydial
infection at a final concentration of 0, 0.2, or 0.8 mM. The
L-arginine concentration in EMEM was 0.6 mM. Some
experiments utilized the addition of excess L-arginine at 2.4
mM (final concentration) at the time of IFN--y priming to
determine whether addition of this substrate of NO synthase
either enhanced or inhibited recovery of infectious progeny
48 and 72 h postinfection. Experiments were done with a
multiplicity of infection (MOI) of 1 (1 IFU: 1 McCoy cell)
unless specified otherwise. Uninfected monolayers received
a sham infection with the same volume (about 5 p,l) of the
standard reaction medium used for freezing chlamydiae,
which contained 10% dimethyl sulfoxide (0.5 ,ul). After
inoculation with chlamydiae or sham infection, the plates
were centrifuged at 1,000 x g for 30 min at 35°C and then
allowed to incubate at 37°C in a 5% CO2 humidified atmo-
sphere.
Plates were allowed to incubate for either 24, 48, or 72 h.
Supernatants were removed at each of these time points, and
samples were frozen at -70°C until nitric oxide metabolites
were assayed. Cell viability was estimated by trypan blue
exclusion assay. Infected monolayers at both 48 and 72 h
postinfection and supernatants remaining at 48 and 72 h were
assayed for chlamydial infectivity as described below.
Quantitation of chlamydial infectivity. Infectivity of EBs
present in either the purified EB fractions used as inocula
(see above) or in McCoy cell monolayers at 48 or 72 h after
chlamydial infection or in supernatants 48 or 72 h postinfec-
tion were quantitated by previously described techniques
(39). (This procedure quantified the infectious progeny orig-
inating from the initial inoculum [MOI = 1] and was mea-
sured at 48 and 72 h postinfection.) Briefly, infected mono-
layers were held at -70°C until subjected to a thaw cycle and
then addition of 1 ml of EMEM, followed by manual
disruption of the monolayers by scraping and repeated
pipetting. This suspension, which had no observable intact
cells, was further subjected to sonication for 1 min in a
Bransonic 12 water bath sonicator (Branson) to facilitate
disaggregation of chlamydiae from cell debris. Purified EBs
which were used as inocula for these experiments were
subjected to a 1-min sonication step prior to the dilution
steps described below. Supernatants taken from infected
monolayers at 48 or 72 h were assayed in a similar fashion.
Duplicate serial 10-fold dilutions of these suspensions were
used to inoculate confluent McCoy cell monolayers supple-
mented by 5% heat-inactivated fetal bovine serum in EMEM
in the presence of 2-,ug/ml cycloheximide in 96-well tissue
culture plates. The plates were centrifuged at 1,000 x g for
30 min, incubated for 72 h, and then stained with Jones
iodine (10) to detect inclusion bodies of chlamydiae by
inverted microscopy at 200x magnification. Total numbers
of chlamydial inclusions in the wells containing the most
diluted observable chlamydial inoculation were determined.
This method was highly reproducible when known inocula of
purified EBs as well as suspensions from infected cells
derived as described above were used. We confirmed the
reproducibility of the sensitivity and specificity of this
method by using fluorescein isothiocyanate-labelled antichla-
mydial monoclonal antibody according to the manufactur-
er's directions (Pathfinder; Kallestad, Chaska, Minn.) in
identically infected confluent McCoy cell monolayers on
removable glass coverslips in tissue culture vials which were
then examined by fluorescence microscopy. This latter
method is in current use. Chlamydial infectivity was ex-
pressed as IFU per milliliter of the original inoculum. In the
24-well experiments described above in "Cytokine priming
prior to chlamydial infection," IFU per milliliter is equal to
total infectious chlamydiae per well present at 72 h after
infection.
Determination of nitrite and nitrate levels. E. coli nitrate
reductase was prepared according to previously described
methods (3). Equal volumes (50 pu1 of each) of E. coli nitrate
reductase suspension and supernatants from control and
infected McCoy cells were mixed and incubated at 37°C for
60 min, with reduction of nitrate to nitrite as described by
Granger et al. (20). The concentration of nitrite was deter-
mined by the Greiss reaction according to a previously
described microassay (16). After incubation, these reaction
mixtures were subjected to centrifugation at 1,000 x g for 10
INFECr. IMMUN.
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FIG. 1. Effects of cytokines and LPS on nitrite production in
McCoy cells. Confluent McCoy cell monolayers (5 x 105 cells per
well) were untreated (medium control) (A) or treated with IFN--y
alone (20 U/ml) (B), TNF-a alone (50 U/ml) (C), IFN--y (20 U/ml)
plus LPS (10 ng/ml) (D), IFN--y (20 U/ml) plus IL-la (10 U/ml) (E),
IFN--y (20 U/ml) plus TNF-a (25 U/ml) (F), or IFN-y (20 U/ml) plus
IL-la (10 U/ml) and TNF-a (25 U/ml) (G). Values are mean total
concentrations of nitrite +2 standard errors of the mean (SEM) (95%
confidence intervals) present in supernatants at 72 h post-cytokine-
LPS treatment from three determinations of a representative exper-
iment. Differences in experimental groups were termed significant
when values fell outside the error bars (P < 0.05).
min, and 50 ,ul of supematant was then removed and mixed
with 100 ,ul of the Greiss reagent [1% sulfanilamide in 30%
acetic acid-0.1% n-(1-naphthyl) diethylene diamine dihydro-
chloride in 60% acetic acid] (1:1), which resulted in an
immediate color change in the presence of nitrite. A480 was
measured in a Beckman DU-65 spectrophotometer. Concen-
trations were calculated from a linear standard curve by
using sodium nitrite at concentrations between 0 and 100 ,uM
which was treated identically to the samples above. Nitrite
concentration was determined for each pair of supernatants
before and after chemical reduction of nitrate by adding 50 ,ul
of supernatant to 100 ,ul of Greiss reagent. Nitrate concen-
tration was then calculated as [nitrate] = [nitrite (reduced
sample)] - [nitrite (nonreduced sample)]. All samples were
done in triplicate, and standard errors were determined.
RESULTS
Production of nitric oxide in McCoy cells following cytokine
stimulation. Priming of McCoy cells with IFN-y or TNF-a
alone did not result in significant production of NO com-
pared with that of medium controls (Fig. 1). However,
IFN--y-primed McCoy cells which were treated with a sec-
ond signal of E. coli LPS, IL-la, or TNF-a were efficient
producers of nitrite, one of the end products of NO synthase
action on L-arginine, as shown in Fig. 1. E. coli LPS and IL-1
appeared to be more effective second signals than TNF-a in
McCoy cells. MLA blocked nitrite production induced by
these second signals (data not shown).
IFN-y effects on chlamydial infectivity and anti-IFN effects
of MLA. Priming of McCoy cell monolayers with IFN--y 24 h
prior to infection with C. trachomatis type H at an MOI of 1
resulted in an IFN dose-dependent decrease in chlamydial
progeny infectivity (Fig. 2, black bars), with a decrease in
chlamydial progeny infectivity of 4 log10 units at 72 h over
the range of 0 to 50 U of IFN--y per ml. This IFN effect was
progressively inhibited with increasing doses of MLA in the
culture medium, with partial inhibition at 0.2mM MLA (Fig.
2, hatched bars) and almost complete inhibition at 0.8 mM
MLA (Fig. 2, stippled bars). Virtually all chlamydial infec-
tivity was cell associated, as expected. Supernatants from
these infected monolayers were not found to have significant
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FIG. 2. Effects of IFN-y priming and MLA on chlamydial infec-
tivity 72 h postinfection with an MOI of 1. McCoy cell monolayers
were primed with IFN--y (0 to 50 U/ml) 24 h prior to infection with
C trachomatis type H. At the time of infection, McCoy cell
monolayers received no MLA as a control (black bars) or 0.2 mM
(hatched bars), or 0.8 mM (stippled bars) MLA. The concentration
of L-arginine in the medium was 0.6 mM. Values are mean IFU +2
SEM (95% confidence intervals) for three experiments done in
duplicate except for one experiment with IFN--y at 1 U/ml. Differ-
ences in experimental groups were termed significant when values
fell outside the error bars (P < 0.05).
numbers of IFU (c1 IFU/ml). We also measured IFU
produced by chlamydial progeny present at 48 h postinfec-
tion, with virtually identical results (data not shown).
Examination of McCoy cell monolayers at 48 and 72 h
postinfection using fluorescent monoclonal antibody staining
indicated that IFN-y treatment produced a marked reduction
in both the size and the number of chlamydial inclusions
seen at both 48 and 72 h postinfection. MLA appeared to
partially reverse the antichlamydial effect of IFN--y so that
inclusions were about 40% more numerous and were clearly
larger than those seen in IFN--y-treated monolayers (data not
shown).
Addition of excess L-arginine (2.4 mM) to reaction mix-
tures receiving 0 to 50 U of IFN--y per ml did not alter the
antichlamydial effects of IFN-y, to either significantly in-
crease or decrease recovery of infectious progeny. How-
ever, addition of excess L-arginine did partially reverse
MLA inhibition of NO synthesis in IFN--y-primed McCoy
cells (nitrite concentration ranging from 10.7 + 0.4 ,uM with
0.8 mM MLA treatment to 16.7 + 1.5 ,uM with 0.8 mM MLA
and 2.4 mM L-arginine treatment) measured at 48 h postin-
fection. As the ability of McCoy cells to produce NO was
restored by this increased amount of L-arginine, we ob-
served a reduction of 3 log10 units in recoverable chlamydial
progeny (IFU) present at 48 h postinfection (5.3 x 1010
IFU/ml with 0.8 mM MLA versus 1.9 x 107 IFU/ml with 0.8
mM MLA plus 2.4 mM L-arginine).
Trypan blue exclusion was used to estimate cell viability
of infected and uninfected McCoy cell monolayers at 24, 48,
and 72 h post-chlamydial inoculation. Viability was >95% at
all time points for uninfected cells primed with IFN--y alone
or in combination with MLA. Viability of infected cells was
approximately 95% through 48 h, but at 72 h cell viability
decreased to approximately 50% but was similar in all
infected treatment groups.
Nitric oxide synthesis associated with reduction of chlamy-
dial infectivity. The ability of IFN--y to reduce chlamydial
infectivity was paralleled by an increase in NO synthesis,
represented by nitrite-nitrate in the culture supernatants.
MLA inhibited NO synthesis in a dose-dependent fashion
(Fig. 3). McCoy cells infected with chlamydiae in the ab-
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FIG. 3. Effects of MLA and IFN--y priming on production of
nitric oxide metabolites in McCoy cell monolayers infected with C.
trachomatis type H at an MOI of 1. Total concentrations of nitrite
plus nitrate, expressed as micromoles per liter present in superna-
tants at 72 h postinfection, from cultures treated with no MLA as a
control (solid squares) or with 0.2 mM (open circles) or 0.8 mM
(solid triangles) MLA are shown at IFN--y concentrations ranging
from 0 to 50 U/ml. Values are mean total concentrations of nitrite
plus nitrate ±2 SEM (95% confidence intervals) for three experi-
ments done in duplicate except for one experiment with IFN--y at 1
U/ml. Differences in experimental groups were termed significant
when values fell outside the error bars (P < 0.05).
sence ofMLA (Fig. 3, closed squares) synthesize NO, which
reached a plateau when IFN--y (10 U/ml) was present. When
0.2 mM MLA was added to the culture medium, there was a
significant decrease in the ability of McCoy cells to synthe-
size NO (Fig. 3, open circles), and this was further dimin-
ished at 0.8 mM MLA (Fig. 3, closed triangles). In the
absence of chlamydial infection, NO production was not
affected by increasing concentrations of IFN--y in the me-
dium and remained at baseline levels (data not shown). Total
nitric oxide synthesis at 48 and 72 h was inversely related to
measured recoverable chlamydial IFU obtained at those
times. The inhibition of NO synthesis was found to be MLA
dose dependent.
Effect of timing of IFN-y dose on NO production. The time
at which IFN-y was added to infected McCoy cells was
important in determining the amount and rate of NO synthe-
sis. As seen in Fig. 4, IFN--y (10 U/ml) added 24 h prior to,
or coincident with, chlamydial infection (MOI of 1) was
associated with maximal NO production. This effect reached
a peak 72 h after exposure to IFN--y, regardless of whether
IFN--y remained in the medium throughout the experiment or
was removed at the time of infection. When IFN--y was
added 24 h or later postinfection, NO production was similar
to that seen in McCoy cells with chlamydia infection alone.
Uninfected controls primed with IFN--y showed minimal
baseline NO production. The rate of NO production ap-
peared to be relatively constant over 72 h within each
treatment group, with the possible exception of the two
-24-h IFN--y groups, in which NO production appeared to
plateau at 48 h postinfection.
DISCUSSION
C. trachomatis, an obligate intracellular parasitic bacte-
rium, is the leading cause of preventable blindness in the
world (31), as well as the leading cause of sexually transmit-
ted disease in the United States (8). Because infection with
this organism does not confer protective immunity, under-
standing host defense mechanisms which eradicate or impede
the growth of this parasite may prove useful in designing
effective means of prevention. Natural defense mechanisms
such as cytokine-mediated killing of intracellular pathogens are
24 48
Time of Infection (hr)
FIG. 4. Effect of timing of IFN--y dose on NO synthesis in
McCoy cells relative to chlamydial infection. IFN-y (10 U/ml) was
added at various time points relative to chlamydia infection (zero
time) as indicated. IFN--y remained in the medium for the duration of
the experiments except for the treatment at -24 h plus a wash, in
which IFN--y was added 24 h prior to infection, with removal and
replacement of the medium immediately prior to infection. Experi-
mental groups were treated with IFN at -24 h plus a wash (open
circles), -24 h (open diamonds), 0 h (dotted line), 24 h (closed
circles), or 48 h (closed squares) or were uninfected with no added
IFN--y (open squares) or uninfected with IFN--y added at -24 h
(open triangles). Supernatants were collected at the time points
indicated and assayed for nitrite and nitrate. Values are mean total
concentrations of nitrite plus nitrate (expressed as micromoles per
liter) +2 SEM (95% confidence intervals) from four determinations
of a representative experiment. Differences in experimental groups
were termed significant when values fell outside the error bars (P <
0.05).
important immunologic means which maintain the balance of
the host-parasite relationship in favor of the host. IFN-y
priming ofboth macrophage and nonmacrophage cell lines is an
example of one such host defense mechanism which has
known potent antichlamydial activity (4-6, 13, 14, 28, 39,
42-44). While chlamydial specificity for mucosal tissue may be
related to specific host cell-parasite interactions, it may in part
be related to relative deficiency of IFN--y production in muco-
sal tissues. Immunologic studies in murine models indicate that
lymphocytes which are found in lymph nodes draining mucosal
surfaces are consistently low-level producers of IL-2 and
IFN--y, in contrast to the lymph nodes draining skin (lOa, 11).
It would be advantageous to this pathogen to establish its
primary sites of infection in tissues with low levels of basal
local IFN--y production.
While at least part of the observed IFN--y antichlamydial
effect in human cells is dependent on enzymatic degradation
of tryptophan by indoleamine 2,3-dioxygenase (reversible by
addition of extracellular tryptophan) (5, 36, 40), antichlamy-
dial IFN--y effects are not mediated by this mechanism in
murine-derived cell lines (12, 36).
In our investigations of the antichlamydial role of IFN--y in
McCoy cells, we established that McCoy cells were efficient
producers of nitric oxide when primed with IFN--y and
exposed to second signals such as IL-1, E. coli LPS, and
TNF-ao (Fig. 1) or chlamydiae (Fig. 3). To our knowledge,
this is the first report which details nitric oxide production by
McCoy cells. Previous investigators determined that other
nonmacrophage murine cell lines are efficient producers of
NO (2), and our results were not unexpected. It appears that
for optimal production of NO in McCoy cells, IFN-,y priming
must precede or at least be coincident with chlamydial
infection (Fig. 4). It appears that maximal inducible NO
synthesis in McCoy cells occurs even if IFN--y is removed
prior to chlamydial infection. While we determined that
INFECT. IMMUN.
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McCoy cells primed with IFN-y 24 h prior to infection with
chlamydiae were efficient producers of NO, it will be impor-
tant to determine how far prior to chlamydial infection
IFN-y priming of McCoy cell will induce NO production and
produce antichlamydial effects. This knowledge will further
our understanding of cytokine-induced defense mechanisms
for control of intracellular parasitism. The finding that Mc-
Coy cells synthesize NO efficiently under these conditions
allowed us to test the hypothesis that IFN--y induces its
antichlamydial activity in McCoy cells through the effector
molecule nitric oxide.
Inducible nitric oxide production following stimulation of
cells with IFN-y appears to be a conserved mechanism for
cells to control proliferation of other intracellular pathogens,
such as T. gondii (1), Plasmodium yoelli (37), and Mycobac-
tenium tuberculosis (9, 15). Both macrophages and nonmac-
rophage cell lines are capable of high-level production of NO
when they receive the appropriate sequence of cytokine
stimulation (2, 16, 18-20, 24, 27). Cells which are primed
with IFN--y and are subsequently exposed to second signals
such as IL-1, TNF-a, or LPS are able to generate high levels
of NO. This sequence of signalling results in induction of
nitric oxide synthase, which produces NO by oxidative
deimination of one of the terminal guanidino nitrogens of
L-arginine. This enzyme is inhibited by the L-arginine analog
MLA (24, 27).
Our data indicate that IFN--y-induced nitric oxide produc-
tion is required for antichlamydial activity in IFN-,y-treated
McCoy cells. The 4-log-unit decrease in infectivity of
chlamydial progeny remaining 72 h postinfection over the
range of IFN--y used (0 to 50 U/ml) shown in Fig. 2 was
accompanied by a corresponding IFN--y dose-dependent rise
in NO as shown in Fig. 3. Chlamydial IFU present at 48 h
postinfection revealed a virtually identical pattern of
chlamydial growth inhibition and NO production (data not
shown). We demonstrated that MLA, a specific competitive
inhibitor of nitric oxide synthase activity, progressively
inhibited in a dose-response manner the antichlamydial
activity of IFN-y (Fig. 3). In fact, chlamydiae appear to
multiply equally well in the presence of IFN-y and in its
absence, if nitric oxide synthesis is blocked by MLA.
Although IFN--y is essential to establish antichlamydial
activity in this model, our data show that NO must be
synthesized to effect this activity and NO appears to be a
final effector molecule of IFN--y-mediated antichlamydial
activity in McCoy cells.
In experiments in which we supplemented IFN-treated
cells with excess L-arginine (2.4 mM) in addition to the
normal concentration in EMEM (0.6 mM), we found no
increase in progeny recovered at either 48 or 72 h when
McCoy cells were primed with IFN--y. In monolayers primed
with IFN-,y and treated with 0.8 mM MLA which were
supplemented with excess L-arginine, a 3-log1o-unit decrease
in progeny recovery was noted. This reduction in recovery
of infectious progeny in the presence of excess L-arginine
was accompanied by a rise in nitrite production. This is in
agreement with the findings of other groups who have found
similar effects with excess L-arginine (1, la) and suggests
that NO production, not L-arginine depletion, is the event
which leads to decreased infectivity of chlamydial progeny
at 48 and 72 h postinfection.
The mechanism through which nitric oxide synthesis
affects chlamydial infectivity in McCoy cells is not yet
understood and is the subject of our current investigations.
Nitric oxide may kill chlamydiae, or it may inhibit chlamy-
dial growth. Growth inhibition could occur in several ways,
e.g., inhibition of EB-to-RB transformation, which would
stop replication, or inhibition of RB-to-EB transformation,
which would inhibit infectivity despite replication. Nitric
oxide may also in some way induce chlamydiae to become
dormant. Our studies using fluorescein-labelled monoclonal
antichlamydial LPS antibodies to observe the development
of chlamydial inclusions in McCoy cells treated with IFN
indicate that both the size and the number of chlamydial
inclusions present in this treatment group are markedly
reduced compared with those of either non-IFN-treated
McCoy cells or McCoy cells treated with IFN plus MLA
which have received an identical MOI (data not shown). This
finding could be compatible with either killing of chlamydiae
or inhibition of chlamydial replication by NO synthesis
induced in McCoy cells. The IFU determinations in Fig. 2
indicate that infectious progeny present 72 h after infection
in the McCoy cells treated with 25 and 50 U of IFN--y per ml
have approximately 104 IFU present, compared with the
initial inoculum of 5 x 105 IFU used to infect these cells.
This decrease of 1 log1o unit in recoverable infectious
progeny compared with the starting inoculum could be
compatible with both modest chlamydial killing and pro-
nounced inhibition of chlamydial growth.
Nitric oxide could have direct effects on chlamydiae to be
chlamydiacidal or chlamydiastatic, as has been demon-
strated with leishmanias, which are susceptible to direct
effects of NO (27, 35). A potential chlamydial target of NO
would include chlamydial enzymes necessary for chlamydial
DNA replication, such as ribonucleotide reductase (40a), an
enzyme which is known to be susceptible to the effects of
NO in other cell types (33a). NO may also mediate its
antichlamydial effects by affecting the host McCoy cells. In
studies of macrophage killing of tumor cells induced by
IFN-y, nitric oxide production is associated with tumoricidal
activity through its ability to form complexes with iron-
sulfur complexes of redox enzymes (17, 18, 24, 26, 27, 32,
38). Additionally, nitric oxide has a known effect on mito-
chondrial respiration which may limit the ability of host cells
to produce ATP (18, 24, 27, 41). If host cell ATP production
is significantly decreased by NO synthesis in our model,
chlamydial growth, which is dependent on ATP parasitism,
could be impaired significantly. Finally, nitric oxide could
affect both host cells and chlamydiae directly. We do not
know at this time whether a certain threshold level of NO
production is required for antichlamydial activity, as other
investigators have suggested for leishmanias (34).
Our data and the data of previous investigators indicate
that intracellular pathogens may provide second signals to
cells which have been primed with IFN-,y, leading to control
of parasitism through NO production. For chlamydiae, it will
be extremely important to identify the second signal pro-
vided by chlamydiae. For example, if the molecule(s) pro-
viding a second signal is included in a chlamydial vaccine,
neutralizing antibodies to the second signal could theoreti-
cally block the ability of host cells to activate the nitric oxide
pathway, which we have shown to have a potent inhibitory
effect on chlamydial proliferation in this murine cell line.
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